iCleanse, a provider of UV-C personal device disinfection, joined forces with CIT to provide low-interest financing on all iCleanse disinfection products.

This alliance will allow iCleanse to better serve its current and future customer base, who may have limited cash flow due to the COVID-19 pandemic, making UV-C disinfection more attainable for small and large businesses alike. iCleanse products kill 99.9% of infectious pathogens, including COVID-19, the common cold and influenza. Through the financing program with CIT, iCleanse customers will receive a decision on financing often in fewer than three minutes.

“Being able to offer our customers an easy financial solution to purchase our products is a no-brainer,” Chris Allen, CEO of iCleanse, said. “Ensuring easy and effective disinfection of the items we use daily is one way to reduce the spread of the COVID-19 pandemic.”